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Peter H. Lin (Houston, Tex). Dr. Timaran and colleagues
from the University of Texas Southwestern Medical Center pre-
sented an excellent study in which they analyzed the predictive
factors of plaque embolization during carotid stenting using vari-
ous imaging modalities, which included virtual histology IVUS,
transcranial Doppler, and diffusion-weighted MRI. The authors
reported a weak correlation regarding the risk of plaque emboliza-
tion as assessed by virtual histology IVUS during carotid artery
stenting. However, patients with high calcium plaque volume are
associated with an increased risk of subclinical cerebral emboliza-
tion.
I have three questions for the authors:
The risk of carotid plaque embolization during carotid
artery stenting has been a subject of intense investigation over
the past decade. There are emerging data to show that hypo-
echoic plaque as assessed by grayscale median analysis using
conventional carotid duplex scan is associated with an increasedment can also be analyzed by intravascular ultrasound. Can you
share with us your thoughts regarding the role of plaque
echomorphology using grayscale median analysis as determined
by either IVUS or carotid duplex ultrasound with regards to the
risk of plaque embolization?
Regarding my second question, there are emerging reports
from the European colleagues suggesting a protective role of statin
therapy, which may stabilize carotid plaques and reduce the possi-
bility of plaque progression as well as plaque embolization during
carotid interventions. Conversely, patients with poorly controlled
hyperlipidemia have been shown to have a higher risk of stroke
following carotid interventions, presumably due to a high risk of
plaque embolization. Did you examine the lipid profile of your
patients, and can you share your thoughts on the role of statin
therapy regarding the risk of carotid plaque embolization?
Lastly, what clinical practice implications can you provide,
based on the findings of your study, so that carotid stenting
procedures can be performed in a safer manner? Should we con-
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Volume 52, Number 5 Timaran et al 1195sider a neuroprotective filter device with smaller porosity when
encountering high calcium volume plaque density? Or should we
use a flow-reversal neuroprotective device when encountering
plaque with high calcium or fibrofatty volume?
I enjoyed this presentation and would also like to congratulate
the authors for a well-designed and well-presented study. I would
also like to thank the authors for providing me with a well-written
manuscript in a timely fashion. Lastly, I would like to thank the
Association for the opportunity to discuss this study.
Carlos Timaran. Thank you, Peter, for your comments and
questions. I do believe that assessing plaque composition is impor-
tant prior to any carotid intervention. Not to mention, the gray
scale median (GSM) is one of the most important methods and its
importance is that it is derived from a noninvasive imaging modal-
ity (ie, duplex ultrasound). There are some studies that have shown
that low GSM is associated with increased risk of embolization
after carotid stenting. We are prospectively collecting duplex ultra-
sound images to correlate the degree of embolization with our VH
IVUS findings and GSM. Unfortunately, I don’t have those data
with me today, but I think those are important and may allow us to
identify patients at high risk of embolization prior to carotid
stenting. Regarding the use of statins, more than 90% of ourpatients were on statins, so what you are seeing here is carotid
plaques that were developed in the presence of a statin. There are
studies that actually show that statins can modify the plaque
composition; specifically, they may decrease the amount of lipids in
the carotid plaque. I do believe that this finding has implications,
particularly for those patients that will be managed with best
medical therapy. Regarding the effectiveness of embolic protec-
tion, what we are seeing here is the effects of plaque composition in
patients that are undergoing a procedure under embolic protection
with a filter. Our idea was to see how effective the filters were in
those patients, particularly those with large necrotic core. Regard-
ing recommendations about our findings, I do believe that we need
to explore further the use of this imaging modality (ie, virtual
histology IVUS). There is some information and findings that we
have presented here; one of them is that if you have substantial
dense calcium, you have to be careful about proceeding with
stenting as there was a trend, although not statistically significant,
to increased embolization in these cases. Obviously, different
embolic protection devices may offer different results in terms of
plaque composition, so that needs to be addressed in future
studies, too.
